相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging biomarker roadmap for cancer studies
James P. B. O'Connor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies
Reza Sirous et al.
ABDOMINAL RADIOLOGY (2016)
Perfusion CT imaging of treatment response in oncology
Davide Prezzi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature
Georg A. Bjarnason et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Radiological evaluation of response to treatment: Application to metastatic renal cancers receiving anti-angiogenic treatment
S. Ammari et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2014)
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
Temel Tirkes et al.
RADIOGRAPHICS (2013)
Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma
Paul Nathan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials
Edward Leen et al.
EUROPEAN RADIOLOGY (2012)
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
James P. B. O'Connor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Evaluation of Treatment Response in Patients with Metastatic Renal Cell Carcinoma: Role of State-of-the-Art Cross-Sectional Imaging
Venkata S. Katabathina et al.
CURRENT UROLOGY REPORTS (2012)
On the Scope and Interpretation of the Tofts Models for DCE-MRI
Steven P. Sourbron et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Dynamic Microbubble Contrast-enhanced US to Measure Tumor Response to Targeted Therapy: A Proposed Clinical Protocol with Results from Renal Cell Carcinoma Patients Receiving Antiangiogenic Therapy
Ross Williams et al.
RADIOLOGY (2011)
Assessment of Response to Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: CT Texture as a Predictive Biomarker
Vicky Goh et al.
RADIOLOGY (2011)
IMPROVED FLOW MEASUREMENT USING MICROBUBBLE CONTRAST AGENTS AND DISRUPTION-REPLENISHMENT: CLINICAL APPLICATION TO TUMOUR MONITORING
John M. Hudson et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2011)
Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy
Andrew Dennis Smith et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
A. A. M. van der Veldt et al.
BRITISH JOURNAL OF CANCER (2010)
Pretreatment Assessment of Tumor Enhancement on Contrast-Enhanced Computed Tomography as a Potential Predictor of Treatment Outcome in Metastatic Renal Cell Carcinoma Patients Receiving Antiangiogenic Therapy
Kyung Seok Han et al.
CANCER (2010)
CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies
Paul D. Nathan et al.
CANCER BIOLOGY & THERAPY (2010)
Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography
Nathalie Lassau et al.
CLINICAL CANCER RESEARCH (2010)
Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: Current status and perspectives
Michele Lamuraglia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Metastatic Renal Carcinoma: Evaluation of Antiangiogenic Therapy with Dynamic Contrast-enhanced CT
Laure S. Fournier et al.
RADIOLOGY (2010)
Physical phenomena affecting quantitative imaging of ultrasound contrast agents
E. Stride et al.
APPLIED ACOUSTICS (2009)
Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy
I. M. E. Desar et al.
CANCER TREATMENT REVIEWS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
QUANTIFICATION OF FLOW USING ULTRASOUND AND MICROBUBBLES: A DISRUPTION REPLENISHMENT MODEL BASED ON PHYSICAL PRINCIPLES
John M. Hudson et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2009)
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
Keith T. Flaherty et al.
CANCER BIOLOGY & THERAPY (2008)
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma
Olwen M. Hahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J. P. B. O'Connor et al.
BRITISH JOURNAL OF CANCER (2007)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging
TE Yankeelov et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2006)
Functional CT: physiological models
Ting-Yim Lee
TRENDS IN BIOTECHNOLOGY (2002)
分享论文
